6-Methyl-3,5-heptadien-2-one
Common Name: |
6-Methyl-3,5-heptadien-2-one |
IUPAC Name: |
(3E)-6-methylhepta-3,5-dien-2-one |
Molecular Formula: |
C8H12O |
SMILES: |
CC(=CC=CC(=O)C)C |
Inchi: |
1S/C8H12O/c1-7(2)5-4-6-8(3)9/h4-6H,1-3H3/b6-4+ |
Inchi Key: |
KSKXSFZGARKWOW-GQCTYLIASA-N |
Cas No: |
1604-28-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
124.18 |
Mass (g/mol) |
124.089 |
Molar Refractivity |
39.82 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
|
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
190.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.464 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.38 |
LogP |
2.098 |
iLOGP |
2.14 |
XLOGP3 |
2.04 |
WLOGP |
2.10 |
MLOGP |
1.87 |
ESOL Log S |
-1.76 |
ESOL Solubility (mg/ml) |
2.14 |
ESOL Solubility (mol/l) |
0.017 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.03 |
Ali Solubility (mg/ml) |
1.17 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.13 |
Silicos-IT Solubility (mg/ml) |
9.29 |
Silicos-IT Solubility (mol/l) |
0.07 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.61 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.39 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.427 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |